C3a 70-77

C3a (70-77) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
C3a 70-77(CAS 63555-63-5)

CAT No: R1257

CAS No:63555-63-5

Synonyms/Alias:63555-63-5;Complement 3a (70-77);C3a (70-77);Ala-Ser-His-Leu-Gly-Leu-Ala-Arg;C3a (70-77) trifluoroacetate salt H-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg-OH trifluoroacetate salt;SCHEMBL11054592;C3a (70-77) trifluoroacetate salt;AKOS040759146;DA-51513;FC108495;H-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg-OH; H-ASHLGLAR-OH;2-(2-{2-[2-(2-{2-[2-(2-aminopropanamido)-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido}-4-methylpentanamido)acetamido]-4-methylpentanamido}propanamido)-5-carbamimidamidopentanoic acid;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C35H61N13O10
M.W/Mr.
823.9
Sequence
One Letter Code:ASHLGLAR
Three Letter Code:H-DL-Ala-DL-Ser-DL-His-DL-Leu-Gly-DL-Leu-DL-Ala-DL-Arg-OH

C3a 70-77 is a synthetic peptide fragment corresponding to amino acid residues 70 through 77 of the human complement component C3a. As an active region derived from the complement system, this peptide is of significant interest in immunological and biochemical research, particularly for its role in innate immune signaling and inflammatory processes. Its concise sequence captures a functionally relevant domain of C3a, enabling targeted investigations into receptor interactions, signaling mechanisms, and peptide-mediated modulation of biological pathways. Researchers utilize this fragment to dissect the specific contributions of C3a subregions to complement activation and downstream cellular responses, making it a valuable tool for advancing understanding of immune function at the molecular level.

Receptor Binding Studies: The C3a 70-77 peptide is widely employed to investigate the molecular determinants of C3a receptor (C3aR) activation and specificity. By isolating this defined sequence, researchers can examine how discrete C3a motifs interact with C3aR or related G protein-coupled receptors on immune cells. Such studies are essential for mapping ligand-binding sites, elucidating structure-activity relationships, and characterizing the minimal sequence requirements for receptor engagement. Insights gained from these experiments inform broader efforts to design selective agonists or antagonists for complement receptors, with implications for modulating immune responses in experimental systems.

Signal Transduction Research: Utilization of the C3a 70-77 fragment enables detailed exploration of intracellular signaling cascades initiated by complement-derived peptides. By applying this defined segment to cultured cells or membrane preparations, investigators can monitor downstream events such as calcium mobilization, MAP kinase activation, or chemotactic responses. Such experiments help to delineate the contribution of specific C3a domains to signaling potency and pathway selectivity, providing a mechanistic foundation for understanding how complement peptides orchestrate cellular communication during immune activation.

Peptide Structure-Function Analysis: The defined nature of the C3a 70-77 sequence makes it a valuable probe for structure-function relationship studies within the complement system. Researchers leverage this peptide to assess how truncations or sequence modifications affect biological activity, receptor recognition, or stability. Such analyses support rational peptide engineering and facilitate the identification of critical residues responsible for functional effects. These investigations are integral to the broader field of peptide-based tool development and complement biology.

Immunomodulation Assays: In vitro and ex vivo experiments frequently employ the C3a 70-77 peptide to evaluate its capacity to modulate immune cell behavior. By exposing leukocytes, mast cells, or other immune effectors to this segment, scientists can assess changes in cytokine secretion, degranulation, or migration. These assays help pinpoint the immunoregulatory properties of specific C3a regions and provide insight into the mechanisms by which complement fragments influence inflammatory processes. Such findings are crucial for advancing knowledge of innate immunity and for developing new research models.

Peptide Synthesis and Analytical Validation: The availability of the C3a 70-77 fragment supports method development in peptide synthesis and analytical characterization. Laboratories use this peptide as a reference standard or positive control in chromatographic, mass spectrometric, or spectroscopic assays, enabling the optimization of peptide purification, identification, and quantification protocols. Its defined sequence and relevance to complement biology make it a benchmark for validating synthetic and analytical workflows, thereby supporting quality assurance in peptide research and production environments.

Length
8
InChI
InChI=1S/C35H61N13O10/c1-17(2)10-23(46-32(55)25(12-21-13-39-16-42-21)47-33(56)26(15-49)48-28(51)19(5)36)30(53)41-14-27(50)44-24(11-18(3)4)31(54)43-20(6)29(52)45-22(34(57)58)8-7-9-40-35(37)38/h13,16-20,22-26,49H,7-12,14-15,36H2,1-6H3,(H,39,42)(H,41,53)(H,43,54)(H,44,50)(H,45,52)(H,46,55)(H,47,56)(H,48,51)(H,57,58)(H4,37,38,40)
InChI Key
LYTNSBOBASKUDN-UHFFFAOYSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesPeptide Synthesis ServicesPeptide Modification ServicesCustom Conjugation ServicePeptide CDMOcGMP Peptide ServiceEpitope Mapping ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers